These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29056152)

  • 1. Orexin/Hypocretin System: Role in Food and Drug Overconsumption.
    Barson JR; Leibowitz SF
    Int Rev Neurobiol; 2017; 136():199-237. PubMed ID: 29056152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S.
    Ubaldi M; Giordano A; Severi I; Li H; Kallupi M; de Guglielmo G; Ruggeri B; Stopponi S; Ciccocioppo R; Cannella N
    Biol Psychiatry; 2016 Mar; 79(6):452-62. PubMed ID: 26055195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity.
    Olney JJ; Navarro M; Thiele TE
    Alcohol Clin Exp Res; 2015 Jan; 39(1):21-9. PubMed ID: 25623402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors.
    Hopf FW
    Neuropharmacology; 2020 May; 168():108013. PubMed ID: 32092435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior.
    Barson JR
    Brain Res; 2020 Mar; 1731():145915. PubMed ID: 30125533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.
    Simmons SJ; Gentile TA
    Brain Res; 2020 Mar; 1731():146164. PubMed ID: 30796894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in orexin research--2010 to 2015.
    Boss C; Roch C
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2875-87. PubMed ID: 26045032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats.
    Brown RM; Khoo SY; Lawrence AJ
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2067-79. PubMed ID: 23601187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.
    James MH; Fragale JE; O'Connor SL; Zimmer BA; Aston-Jones G
    Neuropharmacology; 2021 Feb; 183():108359. PubMed ID: 33091458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential orexin/hypocretin expression in addiction-prone and -resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake.
    Holtz NA; Zlebnik NE; Carroll ME
    Neurosci Lett; 2012 Jul; 522(1):12-5. PubMed ID: 22668854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?
    Cortese S; Konofal E; Lecendreux M
    Med Hypotheses; 2008 Nov; 71(5):770-5. PubMed ID: 18678446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Orexins/Hypocretins in Alcohol Use and Abuse.
    Walker LC; Lawrence AJ
    Curr Top Behav Neurosci; 2017; 33():221-246. PubMed ID: 27909991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice.
    Blais A; Drouin G; Chaumontet C; Voisin T; Couvelard A; Even PC; Couvineau A
    PLoS One; 2017; 12(1):e0169908. PubMed ID: 28085909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
    Xu TR; Yang Y; Ward R; Gao L; Liu Y
    Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neuropeptide Orexin-A Inhibits the GABA
    Sachidanandan D; Reddy HP; Mani A; Hyde GJ; Bera AK
    J Mol Neurosci; 2017 Apr; 61(4):459-467. PubMed ID: 28105535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypocretin/orexin system: implications for drug reward and relapse.
    Plaza-Zabala A; Maldonado R; Berrendero F
    Mol Neurobiol; 2012 Jun; 45(3):424-39. PubMed ID: 22430644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional roles of orexin/hypocretin receptors in reward circuit.
    Haghparast A; Fatahi Z; Arezoomandan R; Karimi S; Taslimi Z; Zarrabian S
    Prog Brain Res; 2017; 235():139-154. PubMed ID: 29054286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
    Tsuneki H; Wada T; Sasaoka T
    Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism.
    Goforth PB; Myers MG
    Curr Top Behav Neurosci; 2017; 33():137-156. PubMed ID: 27909992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective orexin receptor antagonists.
    Lebold TP; Bonaventure P; Shireman BT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4761-9. PubMed ID: 23891187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.